Takeda Oncology Stories | Patient & Science Insights
Our Stories and Viewpoints
Explore a curated collection of stories and viewpoints from Takeda’s Oncology leaders and advocates, offering insights into patient-centered care, scientific innovation, emerging technologies, and our commitment to transforming cancer treatment. Discover the voices of those driving change across the oncology landscape.
Explore More
LinkedInAugust 18, 2025
The power of listening is not a novel concept and yet, in our fast-paced and ever-evolving industry, it can sometimes be overlooked. We can meet every deadline and implement effective strategies, but if the process does not include listening to and understanding the patient’s point of view, we’ll end up missing the mark.
“We can meet every deadline and implement effective strategies, but if the process does not include listening to and understanding the patient’s point of view, we’ll end up missing the mark.
May 27, 2025
Inspired by her mother’s personal journey with MDS, PK Morrow discusses the opportunity to introduce new treatment options for patients with myeloid cancers that may improve their experience and potentially reduce the overall burden of the disease.
May 29, 2024
Balancing clinical outcomes with quality of life. Explore how Takeda Oncology prioritizes patient impact alongside survival rates in cancer treatment approaches.
February 29, 2024
Beyond early detection: Learn how Takeda Oncology partners with patient advocacy organizations to bridge care gaps in metastatic colorectal cancer support.
January 30, 2024
Discover how Takeda Oncology leverages artificial intelligence and emerging technologies to advance cancer care, accelerate research, and improve patient outcomes.
August 15, 2023
Cancer treatment extends beyond clinical care. Explore how Takeda Oncology supports patients through mental health, well-being, and holistic approaches to care.
June 1, 2023
Scientific innovation drives cancer breakthroughs. Learn how Takeda Oncology fosters discovery and leverages innate immunity to grow the oncology treatment pipeline.
January 26, 2023
Atlantic Re:think Q&A with Samer Ansari on why data and emerging technologies are critical to discovering and developing new cancer treatments at Takeda Oncology.
November 28, 2022
Financial toxicity impacts cancer patients nationwide. Watch our fireside chat on how Takeda Oncology and Family Reach partner to address this critical issue.
August 26, 2022
Collaboration drives cancer innovation. Explore Takeda Oncology President Teresa Bitetti on patient-centered strategies and our aspiration to cure cancer.
May 16, 2022
Closing the gap between scientific innovation and patient access. Discover how Takeda Oncology reimagines team structures to accelerate cancer care delivery.
February 15, 2022
Liz Lewis explores transforming healthcare for patient access. Learn about value-based pricing, reimbursement innovation & health equity initiatives.
February 2, 2022
Health inequity in oncology demands action. Explore how Takeda Oncology addresses health disparities as an industry-wide responsibility to improve cancer care access.
November 23, 2021
Creating a future without cancer requires collaboration. Key takeaways from The Economist World Cancer Series on improving global cancer care through partnerships.
November 17, 2021
The future of pharmaceutical field teams. Explore how Takeda Oncology reimagines sales excellence, patient engagement, and commercial innovation in oncology.
August 21, 2021
Personal time off fuels creativity and leadership. Takeda Oncology leader shares insights on how vacation and rest drive renewed energy and fresh perspectives.
July 15, 2021
Explore real-world evidence in multiple myeloma treatment. Understand RWE study designs, clinical trial comparisons & observational research methods.
June 9, 2021
Lung cancer diagnosis and treatment have transformed dramatically in 10 years. Discover how Takeda Oncology advocates for patients amid rapid research advances.
May 4, 2021
Teresa Bitetti shares why she joined Takeda Oncology as President after 20+ years in pharma, drawn by game-changing therapies and patient-focused innovation.
September 21, 2020
Recognizing CML during Blood Cancer Awareness Month. Learn about this rare leukemia affecting 8,000 Americans annually and advances in treatment at Takeda Oncology.